Xenon Pharmaceuticals Inc. (XENE)

Xenon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,225	3,014	2,466	1,612	538	339
Market Cap Growth	43.94%	22.20%	53.02%	199.33%	58.76%	112.94%
Enterprise Value	2,536	2,387	1,884	1,068	365	214
PE Ratio	-	-16.52	-19.74	-20.91	-19.22	-8.47
PS Ratio	-	-	261.41	87.41	16.74	49.66
PB Ratio	3.63	3.25	3.42	2.93	3.14	3.69
P/FCF Ratio	-20.59	-19.97	-24.34	-22.52	-10.61	-56.96
P/OCF Ratio	-21.07	-20.74	-25.05	-23.19	-11.19	-71.94
EV/Sales Ratio	-	-	199.75	57.93	11.34	31.37
EV/EBITDA Ratio	-13.83	-13.32	-15.24	-13.70	-13.04	-5.39
EV/EBIT Ratio	-13.55	-13.06	-15.04	-13.54	-12.75	-5.33
EV/FCF Ratio	-16.22	-15.81	-18.60	-14.93	-7.19	-35.98
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.02	0.18
Debt / EBITDA Ratio	-0.06	-0.06	-0.08	-0.11	-0.12	-0.41
Debt / FCF Ratio	-0.07	-0.07	-0.10	-0.12	-0.07	-2.76
Quick Ratio	31.52	23.43	26.12	38.72	12.10	3.28
Current Ratio	31.82	23.65	26.44	39.03	12.30	3.34
Asset Turnover	0	0	0.01	0.05	0.15	0.06
Interest Coverage	-	-	-	-	-59.11	-28.02
Return on Equity (ROE)	-24.30%	-25.20%	-17.80%	-23.10%	-15.30%	-46.90%
Return on Assets (ROA)	-23.30%	-24.00%	-17.30%	-22.00%	-13.40%	-34.30%
Return on Capital (ROIC)	-24.95%	-22.80%	-17.64%	-14.15%	-17.92%	-39.49%
Earnings Yield	-5.85%	-6.05%	-5.07%	-4.78%	-5.20%	-11.80%
FCF Yield	-4.89%	-5.01%	-4.11%	-4.44%	-9.43%	-1.76%
Buyback Yield / Dilution	-18.06%	-10.48%	-38.77%	-26.30%	-33.17%	-33.53%
Total Shareholder Return	-18.06%	-10.48%	-38.77%	-26.30%	-33.17%	-33.53%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).